These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28836303)

  • 21. Identification, characterization, and in silico ADMET prediction of nirmatrelvir and its degradation products using HPLC-PDA and LC-QTOF-MS/MS.
    Kumar MA; Sundararajan R
    Rapid Commun Mass Spectrom; 2024 Oct; 38(20):e9896. PubMed ID: 39185574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LC-MS-MS Characterization of Forced Degradation Products of Fidarestat, a Novel Aldose Reductase Inhibitor: Development and Validation of a Stability-Indicating RP-HPLC Method.
    Talluri MV; Khatoon L; Kalariya PD; Chavan BB; Ragampeta S
    J Chromatogr Sci; 2015 Oct; 53(9):1588-96. PubMed ID: 26014964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of capmatinib degradation in stress conditions including degradation product characterization using ultra-high-performance liquid chromatography-quadrupole-time of flight mass spectrometry and stability-indicating analytical method development.
    Bhangare D; Rajput N; Jadav T; Sahu AK; Sengupta P
    Rapid Commun Mass Spectrom; 2023 Jan; 37(1):e9417. PubMed ID: 36226771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation, Characterization, and Toxicity Study of Stress Degradation Products of Pranlukast Hydrate.
    Prajapati KJ; Kothari CS
    Chem Res Toxicol; 2022 Jul; 35(7):1206-1219. PubMed ID: 35731702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Forced degradation of fingolimod: effect of co-solvent and characterization of degradation products by UHPLC-Q-TOF-MS/MS and 1H NMR.
    Patel PN; Kalariya PD; Gananadhamu S; Srinivas R
    J Pharm Biomed Anal; 2015 Nov; 115():388-94. PubMed ID: 26279369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LC-ESI-QTOF-MS analysis utilizing gas-phase fragmentation reactions subjected to ESI-IS-CID and ESI-CID-MS/MS conditions to study the degradation behaviour of sorafenib tosylate: NMR and in vitro cytotoxicity and apoptosis detection studies of hydrolytic degradation products.
    Johnsirani P; Wani AA; Bharatam PV; Nanjappan S
    J Pharm Biomed Anal; 2020 Jan; 177():112881. PubMed ID: 31542419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of degradation products of silodosin under stress conditions by liquid chromatography/Fourier transform mass spectrometry.
    Pandeti S; Narender T; Prabhakar S; Reddy TJ
    Rapid Commun Mass Spectrom; 2017 Mar; 31(6):572-582. PubMed ID: 28063187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of degradation behavior of besifloxacin, characterization of its degradation products by LC-ESI-QTOF-MS and their in silico toxicity prediction.
    Salunke N; Kharkar PS; Pandita N
    Biomed Chromatogr; 2019 Jun; 33(6):e4489. PubMed ID: 30652327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of stressed degradation products of metoprolol using LC/Q-TOF-ESI-MS/MS and MS(n) experiments.
    Borkar RM; Raju B; Srinivas R; Patel P; Shetty SK
    Biomed Chromatogr; 2012 Jun; 26(6):720-36. PubMed ID: 21989963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification, characterisation and in silico ADMET prediction of ozenoxacin and its degradation products using high-performance liquid chromatography-photodiode array and liquid chromatography-quadrupole time-of-flight-tandem mass spectrometry.
    Matta A; Sundararajan R
    Rapid Commun Mass Spectrom; 2024 Feb; 38(3):e9676. PubMed ID: 38211348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of forced degradation products of ketorolac tromethamine using LC/ESI/Q/TOF/MS/MS and in silico toxicity prediction.
    Kalariya PD; Raju B; Borkar RM; Namdev D; Gananadhamu S; Nandekar PP; Sangamwar AT; Srinivas R
    J Mass Spectrom; 2014 May; 49(5):380-91. PubMed ID: 24809899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and characterization of stress degradants of lacosamide by LC-MS and ESI-Q-TOF-MS/MS: development and validation of a stability indicating RP-HPLC method.
    Ramisetti NR; Kuntamukkala R; Lakshetti S; Sripadi P
    J Pharm Biomed Anal; 2014 Jul; 95():256-64. PubMed ID: 24699370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of stress degradation products of nintedanib by UPLC, UHPLC-Q-TOF/MS/MS and NMR: Evidence of a degradation product with a structure alert for mutagenicity.
    Dhiman V; Balhara A; Singh S; Tiwari S; Gananadhamu S; Talluri MVNK
    J Pharm Biomed Anal; 2021 May; 199():114037. PubMed ID: 33836462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of online liquid chromatography/quadrupole time-of-flight electrospray ionization tandem mass spectrometry for structural characterization of linagliptin degradation products and related impurities.
    Yadav AS; Dornala D; Swain D; Prabha A; Samanthula G
    Rapid Commun Mass Spectrom; 2020 Nov; 34(21):e8874. PubMed ID: 33463844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of degradation products and process-related impurity of sutezolid by liquid chromatography/electrospray ionization tandem mass spectrometry.
    Guo K; Zhang T; Wang Y; Jin B; Ma C
    J Pharm Biomed Anal; 2019 May; 169():196-207. PubMed ID: 30877931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using an innovative Quality-by-Design approach for development of a stability indicating UHPLC method for ebastine in the API and pharmaceutical formulations.
    Schmidt AH; Molnár I
    J Pharm Biomed Anal; 2013 May; 78-79():65-74. PubMed ID: 23454599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Qualitative and quantitative analysis on chemical constituents from Curculigo orchioides using ultra high performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry.
    He Y; Dong X; Jia X; Li M; Yuan T; Xu H; Qin L; Han T; Zhang Q
    J Pharm Biomed Anal; 2015 Jan; 102():236-45. PubMed ID: 25305598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liquid chromatography electrospray ionization tandem mass spectrometry study of nilutamide and its stress degradation products: in silico toxicity prediction of degradation products.
    Ramesh Babu A; Borkar RM; Raju G; Raju B; Srinivas R
    Biomed Chromatogr; 2014 Jun; 28(6):788-93. PubMed ID: 24861745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.